Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Alvocidib

EU orphan designation number: EU/3/07/485   
Active ingredient: Alvocidib
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Chiltern Clinical Research International GmbH
Norsk-Data-Straße 1, 61352 Bad Homburg v.d.H., Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2007 Orphan designation EMEA/OD/059/07 (2007)5264 of 23/10/2007
06/11/2012 Change of name and/or address of sponsor EMEA/OD/059/07
14/08/2014 Transfer of orphan designation EMA/OD/059/07/T/0 (2014)5907 of 12/08/2014
19/10/2016 Change of name and/or address of sponsor
20/02/2018 Change of name and/or address of sponsor